Rituximab in refractory sarcoidosis: a single centre experience
Open Access
- 1 September 2015
- journal article
- case report
- Published by Springer Nature in Clinical and Molecular Allergy
- Vol. 13 (1) , 1-5
Abstract
Sarcoidosis is a granulomatous disease whose outcome varies from spontaneous remission to chronic refractory disease. Provided that steroids represent the gold standard as a first line treatment, many immune suppressants drugs are currently used in the disease management. However, refractory disease is still a great challenge. Rituximab is an anti-CD20 chimeric monoclonal antibody, currently used for the treatment of B cell malignancies and systemic autoimmune diseases. There are few case reports describing the successful use of Rituximab in refractory sarcoidosis with lung, eye, lymph nodes and skin involvement. In this paper we described three different case reports in which Rituximab has been used to treat refractory sarcoidosis and we reviewed the existing literature.Keywords
This publication has 19 references indexed in Scilit:
- Impact of rituximab trials on the treatment of ANCA-associated vasculitisNephrology Dialysis Transplantation, 2013
- Sarcoidosis associated with neuromyelitis opticaJournal of Clinical Neuroscience, 2013
- Rituximab for refractory granulomatous eye diseaseClinical Ophthalmology, 2012
- Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the Autoimmunity and Rituximab RegistryArthritis Care & Research, 2011
- Disturbed Homeostasis and Multiple Signaling Defects in the Peripheral Blood B-Cell Compartment of Patients with Severe Chronic SarcoidosisClinical and Vaccine Immunology, 2011
- Sarcoidosis is a Th1/Th17 multisystem disorderThorax, 2010
- A CASE OF NEUROSARCOIDOSIS SUCCESSFULLY TREATED WITH RITUXIMABNeurology, 2010
- Relapse of severe sarcoidosis with an uncommon peritoneal location after TNFα blockade. Efficacy of rituximab, report of a single caseJoint Bone Spine, 2010
- Rituximab as a treatment alternative in sarcoidosisJoint Bone Spine, 2008
- Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseasesAnnals of the Rheumatic Diseases, 2005